Question 1

What is the catalog number for EGFR-IN-31?

Accepted Answer

The catalog number for EGFR-IN-31 is orb1686010.

Question 2

What sizes are available for EGFR-IN-31?

Accepted Answer

EGFR-IN-31 is available in the following size(s): 25 mg, 50 mg, 100 mg.

Question 3

How many pack sizes does EGFR-IN-31 come in?

Accepted Answer

EGFR-IN-31 is available in 3 different pack sizes.

Question 4

Is EGFR-IN-31 in stock?

Accepted Answer

EGFR-IN-31 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is EGFR-IN-31 used for?

Accepted Answer

EGFR-IN-31 is a potent small molecule inhibitor targeting the epidermal growth factor receptor (EGFR), whose dysregulation is a key driver in cancers like NSCLC. It serves as a valuable research tool for investigating EGFR mutation-related diseases in both cellular and animal model studies.

Question 6

How long will it take to receive this product if it’s custom made?

Accepted Answer

Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.

Question 7

What is the recommended dilution for this antibody?

Accepted Answer

A recommended dilution range for each validated application is provided on the datasheet, but optimal dilution should be titrated for your specific experimental system, sample type, and detection method.

Question 8

What is the recommended storage temperature after reconstitution?

Accepted Answer

Post-reconstitution storage guidance is listed on the datasheet, typically requiring aliquoting and storage at -20°C or -80°C to preserve activity.

EGFR-IN-31

Product Specifications

CAS Number

Field of Research

Smiles

Molecular Formula

Molecular Weight

Storage Conditions

Notes

Available Sizes

Frequently Asked Questions

Explore Other Products

Anti-CB1 (nimacimab biosimilar)mAb

Anti-CB1 (nimacimab biosimilar)mAb

Anti-CB1 (nimacimab biosimilar)mAb

CSA (D-2) PE

Polyclonal Antibody to Peptidase Inhibitor 15 (PI15)

Polyclonal Antibody to Peptidase Inhibitor 15 (PI15)